Should You Buy the Dip on Broadcom Stock?

Broadcom's AI semiconductor revenue rose 143% year over year to $10.8 billion in fiscal Q2, and management expects another 200% year-over-year increase to $16 billion in Q3. The company reiterated a path to $100 billion or more in annual AI revenue by 2027, but the stock sold off nearly 20% from its all-time high because valuation had run ahead of expectations. The article frames Broadcom as still fundamentally strong, but priced for continued upside and vulnerable if growth decelerates.

Analysis

The selloff looks less like a fundamental break and more like a reset of expectations after a stock had outrun the durability of its own narrative. The key second-order issue is that custom AI chips are still a concentration trade: when the market prices AVGO as a quasi-utility on a hypergrowth multiple, any guidance that merely confirms the prior script can trigger de-rating even if the business remains excellent. In other words, the stock is now trading on incremental beats, not on the existence of the AI cycle itself.

The real beneficiary of a post-AVGO reset may be the broader AI supply chain, especially NVDA and the networking/optics ecosystem, because capital can rotate from a single crowded “AI inference winner” into the picks-and-shovels basket. If investors conclude that AVGO’s 2027 revenue path is already broadly understood, they may prefer names with either higher operating leverage or more obvious near-term surprise potential. That creates a subtle relative-value opportunity: AVGO can stay fundamentally strong while still underperforming on multiple compression, which is exactly the kind of setup that helps peers.

The contrarian view is that the market may be underestimating how long the AI capex cycle can persist once custom silicon designs are embedded in hyperscaler roadmaps. If the build-out remains intact through the end of the decade, then the main risk to AVGO is not demand collapse but expectations moving ahead of execution again and again. That argues for treating the name as a trading vehicle with a time horizon of quarters, not years: upside depends on re-acceleration in guidance, while downside comes from any hint that growth is merely meeting the already-optimistic model.

Near term, the stock is vulnerable to another air pocket if the next print lacks a fresh catalyst, because positioning likely remains crowded even after the drawdown. But the selloff also improves the asymmetry for disciplined buyers: the valuation now leaves room for modest multiple recovery if management can prove that the 2027 target is a floor rather than a ceiling. The critical watch item is whether the next two quarters produce enough revision momentum to keep AVGO in the market’s premium bucket.

Key Decisions for Investors

• Buy AVGO only on weakness into the next 1-2 earnings cycles; use a staggered entry rather than all at once, targeting a 12-18 month hold with upside from multiple re-rating if guidance re-accelerates. Risk: if forward estimates stop rising, the stock can de-rate another 10-15% even without any fundamental deterioration.
• Pair trade: long NVDA / short AVGO for 1-2 quarters if you expect capital to favor the name with more visible upside surprise and less valuation sensitivity. This works best if AI capex remains strong but AVGO’s guidance cadence stays repetitive.
• For event-driven traders, consider a short-dated AVGO put spread into the next earnings report if implied volatility does not fully reflect positioning risk. The thesis is not a collapse in fundamentals, but another guidance-confirmation event that fails to clear a high bar.
• If seeking a lower-volatility expression on the AI infrastructure theme, rotate partial exposure from AVGO into the broader semiconductor basket via NVDA or a semi ETF over the next several weeks. The risk/reward is better if you want AI upside without single-name multiple compression risk.
• Set a tactical take-profit framework on any AVGO rebound into prior highs; the stock now has a higher probability of capping out on valuation until the market gets a new catalyst. A move back toward peak levels without estimate revisions is a trim signal, not a chase signal.